v3.25.4
Stock-Based Compensation and Employee Benefit Plan (Tables)
 12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Fair Value Assumptions of Options Awarded
The fair value of each stock option award is estimated on the date of grant using the Black-Scholes option-pricing model using the assumptions in the following table:

Year Ended December 31,
202320242025
Expected term (years)
1.4 - 6.1
6.16.1
Risk-free interest rate
3.6% - 5.0%
4.3% - 4.4%
3.8% - 4.0%
Expected volatility
51.3% - 54.4%
51.8% - 52.7%
50.2% - 50.7%
Expected dividend yield— — — 
Schedule of Stock Option Activity
A summary of stock option and RSU activity under the Company’s equity incentive plans was as follows (in millions, except per share amounts):

Outstanding
Stock Options
Outstanding
Restricted Stock Units
 Number of
Shares		Weighted-
Average
Exercise
Price		Number of
Shares		Weighted-
Average
Grant
Date Fair
Value
Balances as of December 31, 20237 $71.76 30 $85.35 
Granted1 168.18 13 153.36 
Exercised/Vested (3)41.55 (11)119.00 
Canceled— — (2)143.07 
Balances as of December 31, 20245 93.53 30 97.93 
Granted1 139.80 16 136.11 
Exercised/Vested(1)53.34 (11)138.98 
Canceled— — (3)140.20 
Balances as of December 31, 20255 $108.28 32 $99.64 
 Number of
Shares		Weighted-
Average
Exercise
Price		Weighted-
Average
Remaining
Contractual
Life (years)		Aggregate
Intrinsic
Value
Options outstanding as of December 31, 20245 $93.53 5.43$260 
Options exercisable as of December 31, 20244 80.55 4.69253 
Options outstanding as of December 31, 20255 108.28 5.79203 
Options exercisable as of December 31, 20254 94.05 4.48199 
Schedule of RSU Activity
A summary of stock option and RSU activity under the Company’s equity incentive plans was as follows (in millions, except per share amounts):

Outstanding
Stock Options
Outstanding
Restricted Stock Units
 Number of
Shares		Weighted-
Average
Exercise
Price		Number of
Shares		Weighted-
Average
Grant
Date Fair
Value
Balances as of December 31, 20237 $71.76 30 $85.35 
Granted1 168.18 13 153.36 
Exercised/Vested (3)41.55 (11)119.00 
Canceled— — (2)143.07 
Balances as of December 31, 20245 93.53 30 97.93 
Granted1 139.80 16 136.11 
Exercised/Vested(1)53.34 (11)138.98 
Canceled— — (3)140.20 
Balances as of December 31, 20255 $108.28 32 $99.64 
 Number of
Shares		Weighted-
Average
Exercise
Price		Weighted-
Average
Remaining
Contractual
Life (years)		Aggregate
Intrinsic
Value
Options outstanding as of December 31, 20245 $93.53 5.43$260 
Options exercisable as of December 31, 20244 80.55 4.69253 
Options outstanding as of December 31, 20255 108.28 5.79203 
Options exercisable as of December 31, 20254 94.05 4.48199